Ken S. Ho
Advanced in HIV/AIDS

Dr. Ken S. Ho

Infectious Disease
UPMC
Center For Care Of Infectious Diseases (Ccid)
3601 5th Avenue, Suite 700, 
Pittsburgh, PA 
On Staff At
Accepting New Patients

Advanced in HIV/AIDS
UPMC
Center For Care Of Infectious Diseases (Ccid)
3601 5th Avenue, Suite 700, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ken Ho, MD, is certified in infectious disease and internal medicine by the American Board of Internal Medicine. He is affiliated with UPMC Mercy, UPMC Magee-Womens Hospital, and UPMC Presbyterian. He completed his residency and fellowship at the University of Pittsburgh School of Medicine and medical degree at the University of Maryland School of Medicine. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling.

Dr. Ho is rated as an Advanced provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

His clinical research consists of co-authoring 59 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 27 articles and participated in 4 clinical trials in the study of HIV/AIDS.

Specialties
Infectious Disease
Licenses
Internal Medicine in PA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
University of Pittsburgh School of Medicine
Hospital Affiliations
Upmc Presbyterian Shadyside
Languages Spoken
English
Thai
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

CENTER FOR CARE OF INFECTIOUS DISEASES (CCID)
3601 5th Avenue, Suite 700, Pittsburgh, PA 15213
Call: 412-647-7228

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Safety, Tolerability and Immunogenicity of Recombinant HIV Envelope Protein VRC-HIVRGP096-00-VP (Trimer 4571) Vaccine, in HIV-1 Infected Adults on Suppressive ART
Safety, Tolerability and Immunogenicity of Recombinant HIV Envelope Protein VRC-HIVRGP096-00-VP (Trimer 4571) Vaccine, in HIV-1 Infected Adults on Suppressive ART
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2025
Intervention Type: Biological
Study Drug: Trimer 4571 vaccine
Study Phase: Phase 1
A Phase I Study to Evaluate the Safety, Tolerability and Immunogenicity of a Therapeutic HIV Vaccine Composed of Autologous Dendritic Cells Loaded With Autologous Inactivated Whole Virus or Conserved Peptides in ART-treated HIV-infected Adults
A Phase I Study to Evaluate the Safety, Tolerability and Immunogenicity of a Therapeutic HIV Vaccine Composed of Autologous Dendritic Cells Loaded With Autologous Inactivated Whole Virus or Conserved Peptides in ART-treated HIV-infected Adults
Enrollment Status: Completed
Publish Date: October 29, 2025
Intervention Type: Biological
Study Drugs: a1DC + inactivated whole autologous HIV, a1DC + conserved HIV peptides, a1DC + no antigen, pgDC + inactivated whole autologous HIV, pgDC + conserved HIV peptides, pgDC + no antigena1DC
Study Phase: Phase 1
DREAM-01: Optimization of a Tenofovir Enema for HIV Prevention
DREAM-01: Optimization of a Tenofovir Enema for HIV Prevention
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Other, Drug
Study Phase: Phase 1
A Randomized, Double-Blind Phase 1 Safety and Pharmacokinetic Study of Q-Griffithsin Enema Administered Rectally to HIV-1 Seronegative Adults
A Randomized, Double-Blind Phase 1 Safety and Pharmacokinetic Study of Q-Griffithsin Enema Administered Rectally to HIV-1 Seronegative Adults
Enrollment Status: Terminated
Publish Date: July 06, 2023
Intervention Type: Drug, Other
Study Phase: Phase 1
APT-POCT-01: An Open Label, Pharmacokinetic Study of Plasma/Urine/Salivary Drug Concentrations Over Fourteen Days Following Drug Intake Cessation, In HIV-Uninfected Healthy Volunteers Dosing to Steady-state to Further Development of Point of Care Diagnostic Testing
APT-POCT-01: An Open Label, Pharmacokinetic Study of Plasma/Urine/Salivary Drug Concentrations Over Fourteen Days Following Drug Intake Cessation, In HIV-Uninfected Healthy Volunteers Dosing to Steady-state to Further Development of Point of Care Diagnostic Testing
Enrollment Status: Completed
Publish Date: March 03, 2022
Intervention Type: Drug
Study Drugs: Dolutegravir, Emtricitabine/Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, Lamivudine
Study Phase: Early Phase 1
A Phase I, Open-label Multiple Dose Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Tenofovir Rectal Douche
A Phase I, Open-label Multiple Dose Safety, Pharmacokinetic, Pharmacodynamic, and Acceptability Study of Tenofovir Rectal Douche
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase I/II Pilot Study of Dipyridamole as a Modulator of Immune Activation and Systemic Inflammation in HIV-1-Infected Subjects on Antiretroviral Therapy- DAIDS-ES ID 11987
A Phase I/II Pilot Study of Dipyridamole as a Modulator of Immune Activation and Systemic Inflammation in HIV-1-Infected Subjects on Antiretroviral Therapy- DAIDS-ES ID 11987
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

59 Total Publications

Associations of repeated measures of plasma biomarkers of kidney tubular health with longitudinal kidney function in people with HIV.
Associations of repeated measures of plasma biomarkers of kidney tubular health with longitudinal kidney function in people with HIV.
Journal: AIDS (London, England)
Published: July 17, 2025
View All 59 Publications
Similar Doctors
Elite in HIV/AIDS
Dr. John W. Mellors
Infectious Disease
Elite in HIV/AIDS
Dr. John W. Mellors
Infectious Disease

University Of Pittsburgh Physicians, Department Of Medicine, Division Of Infectious Disease

3601 5th Avenue, Falk Clinic Suite 700, 
Pittsburgh, PA 
 (0.1 miles away)
412-946-2738
Languages Spoken:
English, French
See accepted insurances

John Mellors, MD, specializes in infectious diseases and is board-certified in infectious disease and internal medicine by the American Board of Internal Medicine. He is affiliated with UPMC Presbyterian. Dr. Mellors received his medical degree from Dartmouth College Geisel School of Medicine and completed his residency and fellowship at Yale New Haven Hospital. Dr. Mellors is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Sepsis, COVID-19, and Severe Acute Respiratory Syndrome (SARS).

Deborah K. Mcmahon
Distinguished in HIV/AIDS
Dr. Deborah K. Mcmahon
Infectious Disease
Distinguished in HIV/AIDS
Dr. Deborah K. Mcmahon
Infectious Disease

Center For Care Of Infectious Diseases (Ccid)

3601 5th Avenue, Suite 700, 
Pittsburgh, PA 
 (0.1 miles away)
412-530-6772
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Deborah McMahon, MD, is certified in internal medicine and infectious disease by the American Board of Internal Medicine. She practices at University of Pittsburgh Physicians, Department of Medicine, Division of Infectious Disease and is affiliated with UPMC Presbyterian. She completed her fellowship at University of Pittsburgh School of Medicine, residency at Maimonides Medical Center, and medical degree at Temple University School of Medicine. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Mcmahon is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Sepsis, Myelitis, and AIDS Dementia Complex.

Bernard J. Macatangay
Distinguished in HIV/AIDS
Dr. Bernard J. Macatangay
Infectious Disease
Distinguished in HIV/AIDS
Dr. Bernard J. Macatangay
Infectious Disease

Division Of Infectious Diseases/ HIV/AIDS Program

3550 Fifth Avenue, Scaife Hall S827, 
Pittsburgh, PA 
 (2.2 miles away)
412-383-1272
Languages Spoken:
English, Filipino
See accepted insurances

Bernard Macatangay is an Infectious Disease provider in Pittsburgh, Pennsylvania. Dr. Macatangay is rated as an Advanced provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Sepsis, COVID-19, and Severe Acute Respiratory Syndrome (SARS).

VIEW MORE HIV/AIDS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ho's expertise for a condition
ConditionClose
      • Advanced
      • HIV/AIDS
        Dr. Ho is
        Advanced
        . Learn about HIV/AIDS.
        See more HIV/AIDS experts
      • Experienced
      • AIDS Dementia Complex
        Dr. Ho is
        Experienced
        . Learn about AIDS Dementia Complex.
        See more AIDS Dementia Complex experts
      • AIDS Dysmorphic Syndrome
        Dr. Ho is
        Experienced
        . Learn about AIDS Dysmorphic Syndrome.
        See more AIDS Dysmorphic Syndrome experts
      • Human Papillomavirus Infection
        Dr. Ho is
        Experienced
        . Learn about Human Papillomavirus Infection.
        See more Human Papillomavirus Infection experts
      • Myelitis
        Dr. Ho is
        Experienced
        . Learn about Myelitis.
        See more Myelitis experts
      • Rabies
        Dr. Ho is
        Experienced
        . Learn about Rabies.
        See more Rabies experts
      • Severe Acute Respiratory Syndrome (SARS)
        Dr. Ho is
        Experienced
        . Learn about Severe Acute Respiratory Syndrome (SARS).
        See more Severe Acute Respiratory Syndrome (SARS) experts
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.